Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06938191

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in Gingival Crevicular Fluid, Dentin Fluid and Pulp Samples of Healthy and Acute Irreversible Pulpitis Teeth

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Kırıkkale University · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagnosed with irreversible pulpitis and investigate whether there is a correlation between them. A total of 70 patients aged 18-64 years with healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) diagnosed at Kırıkkale University, Faculty of Dentistry, Department of Endodontics who will undergo routine root canal treatment will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, DOS samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. A dentin fluid sample will be taken by holding the membrane on the dentin surface, and the pulp tissue will be removed and transferred to Eppendorf tubes. The treatment process will be completed by applying routine root canal procedures to the teeth. The samples' Aquaporin -4, -5, -9, and IL-8 levels will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).

Detailed description

A total of 70 healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) patients aged 18-64 years, who will undergo routine root canal treatment at Kırıkkale University, Faculty of Dentistry, Department of Endodontics, will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, GCF samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. The tooth from which the GCF sample will be taken will be isolated with cotton pellets. After the supragingival plaque is carefully removed with a curette without touching the gums, the tooth will be dried with light air pressure for 10 seconds and periopaper strips will be placed in the gingival sulcus until resistance is felt. The periopaper strips will be removed from the gingival sulcus after 1 minute. While taking the samples, care should be taken not to contaminate with blood and saliva; contaminated samples will be repeated. The amount of GCF will be measured and recorded using the periotron device. The microliter equivalents of the values measured on the Periotron device will be recorded. Periopaper strips will be placed in 1.5 cc sterile eppendorf tubes. Gingival index and pocket depth measurements will be performed after GCF samples are taken to prevent irritation of periodontal tissues and blood contamination. Patients with a pocket depth of more than 4 mm will be excluded from the study. After anesthesia with 1.8 ml articaine HCl containing 1:100000 epinephrine, the teeth will be isolated with rubber-dam disinfected with 70% alcohol. After disinfection of the tooth crowns and surrounding area with 30% hydrogen peroxide and 2.5% NaOCl, caries and existing restorations, if any, will be removed. In teeth with normal pulp, dentin fluid samples will be taken from the dentin cavity approximately 2 mm away from the pulp as calculated on radiographs. The exposed hard dentin surface will be dried with compressed air. Using a sterile press, 1 membrane per tooth will be applied to the exposed dentin for 1 minute and 1.5 mL will be transferred to a sterile eppendorf tube. The pulp chamber ceiling will be removed with a No. 14 steel rond milling cutter using a micromotor. Using a sterile excavator and tirnerf, healthy and inflamed pulp samples will be removed and transferred to sterile eppendorf tubes to which 200 μl of Phosphate Buffer (PBS) pH:7.2 will be added. While collecting the samples, care should be taken not to contaminate them with blood and saliva; GCF and dentin fluid samples with suspected contamination will be repeated. Patients with samples with contamination of pulp tissue or deterioration in storage conditions will be excluded from the study. GCF, dentin fluid and pulp tissue samples transferred to a 1.5 mL sterile eppendorf tube labeled with a code assigned to the patient with diagnosis and date, with low protein binding, kept immediately on ice, transferred to a freezer and kept at -20 °C. Samples will be transported from the clinic to the freezer at -80°C and stored in a freezer at -80°C to prevent denaturation until further analysis. The treatment process will be completed by applying routine root canal procedures to the teeth. Teeth in the healthy pulp group with an indication for extraction will be extracted after the samples are taken, subjected to normal extraction procedures. Aquaporin -4, -5, -9 and IL-8 levels of the samples will be analyzed by specific enzyme-linked immunosorbent assay (ELISA). Data will be analyzed in computer environment with SPSS 28.0 (Statistical Package for the Social Sciences, NY, USA) statistical package program. Results will be evaluated at 95% confidence interval and p\<0.05 significance level.

Conditions

Timeline

Start date
2025-12-01
Primary completion
2026-02-01
Completion
2026-09-12
First posted
2025-04-22
Last updated
2025-12-01

Source: ClinicalTrials.gov record NCT06938191. Inclusion in this directory is not an endorsement.